S&P 500
$5,842.01
-0.0%
-$2.60
DJI
$41,859.09
-0.0%
-$1.35
NASDAQ
$18,925.73
+0.3%
+$53.09
Bitcoin
111,239.00
+0.5%
+551.68
AAPL
$201.16
-0.5%
-$0.93
AMZN
$202.96
+0.9%
+$1.84
GOOG
$171.96
+1.1%
+$1.90
META
$636.81
+0.2%
+$1.31
MSFT
$454.60
+0.4%
+$2.03
NVDA
$132.90
+0.8%
+$1.10
TSLA
$341.59
+2.1%
+$6.97
Cns Pharmaceuticals (NASDAQ: CNSP)
$1.15
(-5.7%)
-$0.07
Price as of May 22, 2025, 3:58 p.m. ET
Cns Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cns Pharmaceuticals Company Info
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.